LPL Financial’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

LPL Financial’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-11,000	Closed	-$43K	–	2847
2016 Q3	$43K	Hold	11,000	–	–	﹤0.01%	2582
2016 Q2	$60K	Sell	11,000 -9,000	-45%	-$51.3K	﹤0.01%	2548
2016 Q1	$95K	Sell	20,000 -4,000	-17%	-$17.6K	﹤0.01%	2947
2015 Q4	$108K	Buy	24,000 +12,000	+100%	+$51.9K	﹤0.01%	2974
2015 Q3	$55K	Buy	+12,000	New	+$83.4K	﹤0.01%	2708

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

LPL Financial's CPHR Position: Q4 2016 in Review

LPL Financial sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 11,000 shares — an estimated $43K sold.

LPL Financial first reported a position in CPHR in Q3 2015 and held it in 5 quarters. The position peaked at $108K in Q4 2015. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

LPL Financial reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
LPL Financial sold 11,000 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $43K.
LPL Financial first reported a position in Cipher Pharmaceuticals Inc. in Q3 2015 and held it in 5 quarters.
LPL Financial's Cipher Pharmaceuticals Inc. position peaked at $108K in Q4 2015.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on LPL Financial's 13F filing for Q4 2016, filed 13 Feb 2017.